These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
825 related articles for article (PubMed ID: 30240282)
21. Present and future of metabolic and metabolomics studies focused on classical psychedelics in humans. Madrid-Gambin F; Fabregat-Safont D; Gomez-Gomez A; Olesti E; Mason NL; Ramaekers JG; Pozo OJ Biomed Pharmacother; 2023 Dec; 169():115775. PubMed ID: 37944438 [TBL] [Abstract][Full Text] [Related]
22. Psychedelics and mental health: a population study. Krebs TS; Johansen PØ PLoS One; 2013; 8(8):e63972. PubMed ID: 23976938 [TBL] [Abstract][Full Text] [Related]
23. Serotonin 2A Receptor Signaling Underlies LSD-induced Alteration of the Neural Response to Dynamic Changes in Music. Barrett FS; Preller KH; Herdener M; Janata P; Vollenweider FX Cereb Cortex; 2018 Nov; 28(11):3939-3950. PubMed ID: 29028939 [TBL] [Abstract][Full Text] [Related]
24. Therapeutic Potential of Psychedelics in Treatment of Psychiatric Disorders, Part 2: Review of the Evidence. Hosanagar A; Cusimano J; Radhakrishnan R J Clin Psychiatry; 2021 Feb; 82(3):. PubMed ID: 33988930 [No Abstract] [Full Text] [Related]
25. The hidden therapist: evidence for a central role of music in psychedelic therapy. Kaelen M; Giribaldi B; Raine J; Evans L; Timmerman C; Rodriguez N; Roseman L; Feilding A; Nutt D; Carhart-Harris R Psychopharmacology (Berl); 2018 Feb; 235(2):505-519. PubMed ID: 29396616 [TBL] [Abstract][Full Text] [Related]
26. Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT. Griffiths RR; Hurwitz ES; Davis AK; Johnson MW; Jesse R PLoS One; 2019; 14(4):e0214377. PubMed ID: 31013281 [TBL] [Abstract][Full Text] [Related]
27. Is the psychedelic experience an essential aspect of the therapeutic effect of serotonergic psychedelics? Conceptual, discovery, development and implementation implications for psilocybin and related agents. McIntyre RS Expert Opin Drug Saf; 2023; 22(10):885-889. PubMed ID: 37635320 [No Abstract] [Full Text] [Related]
28. Cessation and reduction in alcohol consumption and misuse after psychedelic use. Garcia-Romeu A; Davis AK; Erowid F; Erowid E; Griffiths RR; Johnson MW J Psychopharmacol; 2019 Sep; 33(9):1088-1101. PubMed ID: 31084460 [TBL] [Abstract][Full Text] [Related]
29. Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm. Perkins D; Sarris J; Rossell S; Bonomo Y; Forbes D; Davey C; Hoyer D; Loo C; Murray G; Hood S; Schubert V; Galvão-Coelho NL; O'Donnell M; Carter O; Liknaitzky P; Williams M; Siskind D; Penington D; Berk M; Castle D Aust N Z J Psychiatry; 2021 Dec; 55(12):1127-1133. PubMed ID: 33745287 [TBL] [Abstract][Full Text] [Related]
30. Microdosing psychedelics: personality, mental health, and creativity differences in microdosers. Anderson T; Petranker R; Rosenbaum D; Weissman CR; Dinh-Williams LA; Hui K; Hapke E; Farb NAS Psychopharmacology (Berl); 2019 Feb; 236(2):731-740. PubMed ID: 30604183 [TBL] [Abstract][Full Text] [Related]
31. Human behavioral pharmacology of psychedelics. Strickland JC; Johnson MW Adv Pharmacol; 2022; 93():105-132. PubMed ID: 35341564 [TBL] [Abstract][Full Text] [Related]
32. Serotonergic psychedelics LSD & psilocybin increase the fractal dimension of cortical brain activity in spatial and temporal domains. Varley TF; Carhart-Harris R; Roseman L; Menon DK; Stamatakis EA Neuroimage; 2020 Oct; 220():117049. PubMed ID: 32619708 [TBL] [Abstract][Full Text] [Related]
33. Psychedelic use and intimate partner violence: The role of emotion regulation. Thiessen MS; Walsh Z; Bird BM; Lafrance A J Psychopharmacol; 2018 Jul; 32(7):749-755. PubMed ID: 29807492 [TBL] [Abstract][Full Text] [Related]
34. The neurobiology of psychedelic drugs: implications for the treatment of mood disorders. Vollenweider FX; Kometer M Nat Rev Neurosci; 2010 Sep; 11(9):642-51. PubMed ID: 20717121 [TBL] [Abstract][Full Text] [Related]
35. Decreased directed functional connectivity in the psychedelic state. Barnett L; Muthukumaraswamy SD; Carhart-Harris RL; Seth AK Neuroimage; 2020 Apr; 209():116462. PubMed ID: 31857204 [TBL] [Abstract][Full Text] [Related]
36. The paradoxical psychological effects of lysergic acid diethylamide (LSD). Carhart-Harris RL; Kaelen M; Bolstridge M; Williams TM; Williams LT; Underwood R; Feilding A; Nutt DJ Psychol Med; 2016 May; 46(7):1379-90. PubMed ID: 26847689 [TBL] [Abstract][Full Text] [Related]
37. d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders. De Gregorio D; Enns JP; Nuñez NA; Posa L; Gobbi G Prog Brain Res; 2018; 242():69-96. PubMed ID: 30471683 [TBL] [Abstract][Full Text] [Related]
38. Return of the lysergamides. Part V: Analytical and behavioural characterization of 1-butanoyl-d-lysergic acid diethylamide (1B-LSD). Brandt SD; Kavanagh PV; Westphal F; Stratford A; Elliott SP; Dowling G; Wallach J; Halberstadt AL Drug Test Anal; 2019 Aug; 11(8):1122-1133. PubMed ID: 31083768 [TBL] [Abstract][Full Text] [Related]
39. The future of hallucination research: Can hallucinogens and psychedelic drugs teach us anything? Waters F Psychiatry Res; 2023 Jan; 319():114968. PubMed ID: 36462291 [TBL] [Abstract][Full Text] [Related]